Bleomycin hydrolase immunoreactivity in senile plaque in the brains of patients with Alzheimer's disease

Brain Research

Volumn 830, Issue 1, 1999, Pages 200-202

  Namba, Yoshio ^a   Ouchi, Yasuyoshi ^a   Takeda, Atsushi ^b   Ueki, Akira ^c   Ikeda, Kazuhiko ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAGAMI WOMEN'S UNIVERSITY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Alzheimer's disease; Bleomycin hydrolase; Immunohistochemistry; Protease; Senile plaque

Indexed keywords

AMYLOID; BLEOMYCIN HYDROLASE; CYSTEINE PROTEINASE; HYDROLASE; PAPAIN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; NEOCORTEX; PRIORITY JOURNAL; SENILE PLAQUE; TEMPORAL CORTEX;

ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CYSTEINE ENDOPEPTIDASES; HUMANS; IMMUNOHISTOCHEMISTRY; SENILE PLAQUES;

EID: 0033614713     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01435-3     Document Type: Article

References (13)

1. Brömme D., Rossi A.B., Smeekens S.P., Anderson D.C., Payan D.G. Human bleomycin hydrolase: molecular cloning, sequencing, functional expression, and enzymatic characterization. Biochemistry. 35:1996;6706-6714.
2. Haass C., Selkoe D.J. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell. 75:1993;1039-1042.
3. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
4. Ladror U.S., Snyder S.W., Wang G.T., Holzman T.F., Krafft G.A. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. J. Biol. Chem. 269:1994;18422-18428.
5. Lehmann D.J., Johnston C., Smith A.D. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum. Mol. Genet. 6:1997;1933-1936.
6. Lemere C.A., Munger J.S., Shi G.-P., Natkin L., Haass C., Chapman H.A., Selkoe D.J. The lysosomal cysteine protease, cathepsin S, is increased in Alzheimer's disease and Down syndrome brain. Am. J. Pathol. 146:1995;848-860.
7. Montoya S.E., Ferrell R.E., Lazo J.S. Genomic structure and genetic mapping of the human neutral cysteine protease bleomycin hydrolase. Cancer Res. 57:1997;4191-4195.
8. Montoya S.E., Aston C.E., DeKosky S.T., Kamboh M.I., Lazo J.S., Ferrell R.E. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease. Nat. Genet. 18:1998;211-212.
9. Pericak-Vance M.A., Bass M.P., Yamaoka L.H., Gaskell P.C., Scott W.K., Teewedow H.A., Menold M.M., Conneally P.M., Small G.W., Vance J.M., Saunders A.M., Roses A.D., Haines J.L. Complete genomic screen in late-onset familial Alzheimer disease. JAMA, J. Am. Med. Assoc. 278:1997;1237-1241.
10. Russ C., Powell J., Lovestone S., Holmes C. Kvariant of butyrycholinesterase and late-onset Alzheimer's disease. Lancet. 451:1998;881.
11. Sahasrabudhe S.R., Brown A.M., Hulmes J.D., Jacobsen J.S., Vitek M.P., Blume A.J., Sonnenberg J.L. Enzymatic generation of the amino erminus of the beta-amyloid peptide. J. Biol. Chem. 268:1993;16699-16705.
12. Sauders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
13. Takeda A., Higuchi D., Yamamoto T., Nakamura Y., Masuda Y., Hirabayashi T., Nakane K. Purification and characterization of bleomycin hydrolase, which represents a new family of cysteine proteases, from rat skin. J. Biochem. 119:1996;29-36.